Emiko Kashima

1PUBLICATIONS
0CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 20, 2024
Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation.

Emiko Kashima, Yuka Sugimoto, Keiki Nagaharu

Pageof 1

Frequent Collaborators